Targeting Ovarian Cancer Stem Cells Interactions with the Niche

Abstract

Ovarian cancer (OC) recurrence and spread have been linked to a small population of cancer stem cells (CSC), which are resistant to traditional chemotherapy. Tissue transglutaminase (TG2), an enzyme found to be active in ovarian tumors, protects CSCs and stimulates their growth. We found that this enzyme is enriched at the membrane of OC cells forming a complex with several receptors, such as integrins and the Wnt receptors Frizzled 1, 7 and co-receptor LRP6. This interaction stimulates survival pathways linked with the integrin linked kinase (ILK) activation and CD166 expression in OC cells and maintains the CSC phenotype. We defined the amino acids residues involved in the TG2/Fzd7 interaction and we are using this discovery to design a new treatment for OC by generating an antibody that could disrupt the complex. Our research has several important implications. First, we defined TG2 as novel Wnt pathway co-receptor. Second, the Wnt receptors in a complex with TG2 activate Wnt signals promoting the expression of several stemness-related genes (ALDH1A1, Sox2, and Nanog) and the novel proposed CSC marker CD166 involved in OCSCs' proliferation as spheres. Third, we expanded our research identifying a new functional link between the TG2 regulated cell adhesion to the matrix, integrin linked kinase (ILK) phosphorylation and canonical Wnt signaling activation, proposing ILK as a central node of two combinatorial signals. These results point to TG2/Wnt receptors as potential new therapeutic CSC targets. Ovarian cancer (OC) recurrence and spread have been linked to a small population of cancer stem cells (CSC), which are resistant to traditional chemotherapy. Tissue transglutaminase (TG2), an enzyme found to be active in ovarian tumors, protects CSCs and stimulates their growth. We found that this enzyme is enriched at the membrane of OC cells forming a complex with several receptors, such as integrins and the Wnt receptors Frizzled 1, 7 and co-receptor LRP6.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Aug 01, 2021
Accession Number
AD1159614

Entities

People

  • Salvatore Condello

Organizations

  • Indiana University Bloomington

Tags

DTIC Thesaurus Topics

  • Amino Acids
  • Biomedical Research
  • Cancer
  • Cell Line
  • Cell Membrane Structures
  • Cell Physiological Processes
  • Cells
  • Chemistry
  • Department Of Defense
  • Molecules
  • Neoplasms
  • Ovarian Cancer
  • Procurement
  • Protein-Protein Interactions
  • Proteins
  • Stem Cells
  • Therapy

Fields of Study

  • Biology

Readers

  • Molecular Biology and Genetics
  • Molecular and Cellular Biochemistry
  • Oncology

Technology Areas

  • Biotechnology